FDA Import Refusal SCS-7346576-8/11/1 — GLAXO SMITH KLINE INC
The FDA refused shipment SCS-7346576-8/11/1 from GLAXO SMITH KLINE INC (Canada) on Dec 18, 2019. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 18, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62GAO90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75